Category

Daily Briefs

Most Read: ROHM Co Ltd, Hygon Information Technology C, Amman Mineral Internasional, Greatland Gold, Xero Ltd, FWD Group Holdings, Krungthai Card, Max Healthcare Institute, Tung Ho Steel Enterprise, Ain Holdings Inc and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Nikkei 225 Index Rebalance: Rohm (6963) To Replace NTT Data Group (9613)
  • Hygon/Sugon Merger: BIG Index Flows on Completion
  • Gold Miners ETF (GDX US): Impact of Benchmark Change – Update
  • Greatland Resources (GGP AU): Big Index Inclusions for Recent IPO
  • Xero (XRO AU): Index Flows Following the Capital Raise
  • FWD Group (1828 HK): Offering Details & Index Entry Timeline
  • Krungthai Card (KTC TB): Buying Opportunity After Margin Call
  • Quiddity Leaderboard NIFTY Sep25: Multiple Changes to Expected ADDs/DELs; New Pair Trade Ideas
  • Quiddity Leaderboard T50/​​​100 Sep25: Shin Kong Replacement + One Dark Horse TDIV Potential DEL
  • Ain’s Purchase of Kraft a Sign of More Drugstore M&A to Come


Nikkei 225 Index Rebalance: Rohm (6963) To Replace NTT Data Group (9613)

By Brian Freitas


Hygon/Sugon Merger: BIG Index Flows on Completion

By Brian Freitas


Gold Miners ETF (GDX US): Impact of Benchmark Change – Update

By Brian Freitas

  • The VanEck Gold Miners ETF/USA (GDX US) has announced a benchmark change from the NYSE Arca Gold Miners Index to the MarketVector Global Gold Miners Index.
  • The benchmark change will result in a bunch of constituent and weight changes in September. Estimated one-way turnover is 16.5% resulting in a one-way trade of US$3.15bn.
  • The flow and turnover numbers will change following constituent and capping changes for the MarketVector Global Gold Miners Index at the September rebalance.

Greatland Resources (GGP AU): Big Index Inclusions for Recent IPO

By Brian Freitas


Xero (XRO AU): Index Flows Following the Capital Raise

By Brian Freitas

  • Xero Ltd (XRO AU) has entered into a binding agreement to acquire Melio Limited for an upfront cash consideration of US$2.5bn in cash and Xero Ltd (XRO AU) stock.
  • The cash consideration is being funded mainly through a fully underwritten A$1.85bn (US$1.2bn) institutional placement. There is also a non-underwritten Share Purchase Plan to raise around A$200m.
  • Given the large size of the institutional placement, there will be an increase in index shares and the passive buying that follows should mop up over 20% of the placement.

FWD Group (1828 HK): Offering Details & Index Entry Timeline

By Brian Freitas

  • FWD Group Holdings (FWD HK) is looking to raise up to HK$3.99bn (US$508m) in its IPO, valuing the company at HK$48.82bn (US$6.22bn).
  • Cornerstone investors will take up more than half the base offering and that will delay index inclusion to well into 2026.
  • FWD Group Holdings (FWD HK) could be added to the HSCI Index and Southbound Stock Connect in December. That could bring some buying into the stock from mainland investors.

Krungthai Card (KTC TB): Buying Opportunity After Margin Call

By David Blennerhassett


Quiddity Leaderboard NIFTY Sep25: Multiple Changes to Expected ADDs/DELs; New Pair Trade Ideas

By Janaghan Jeyakumar, CFA

  • NIFTY 50 represents the 50 largest stocks listed in the National Stock Exchange (NSE) of India and the NIFTY Next 50 index tracks the next 50 largest names.
  • In this insight, we take a look at the names leading the race to become ADDs/DELs for these indices during the September 2025 index rebal event.
  • We see two changes for NIFTY 50 and five changes for NIFTY 100 in the September 2025 rebal.

Quiddity Leaderboard T50/​​​100 Sep25: Shin Kong Replacement + One Dark Horse TDIV Potential DEL

By Janaghan Jeyakumar, CFA

  • The T50 index represents the top 50 largest stocks by market capitalization in the Taiwan Stock Exchange (TWSE). The T100 index represents the next 100 largest names (51-150 ranks).
  • In this insight, we take a look at the potential ADDs and DELs for the September 2025 index rebal event.
  • Currently, we see no changes for T50 and one change for T100 in September.

Ain’s Purchase of Kraft a Sign of More Drugstore M&A to Come

By Michael Causton

  • The merger of Tsuruha and Welcia got the green light in May and will further galvanise the sector to consolidate, especially in prescriptions due to the shortage of qualified staff.
  • Which is why Ain has confirmed the acquisition of Kanto-based prescription drug chains operated by Kraft. 
  • The move will help maintain Ain’s dominance in the dispensing pharmacy sector and encourage further M&A.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Australia: Santos Ltd, New World Resources, Commonwealth Bank of Australia, Clarity Pharmaceuticals Ltd, Metcash Ltd, Platinum Asset Management, Ram Essential Services Prope, Artrya and more

By | Australia, Daily Briefs

In today’s briefing:

  • Santos (STO AU): Why FIRB Should Block ADNOC’s Takeover
  • New World Resources (NWC AU): Kinterra Firms A$0.057/Share Off-Market Offer
  • New World Resources (NWC AU): CAML Raises to A$0.062, Next Move Kinterra
  • Commonwealth Bank of Australia – The Overnight Report: Geopolitical Crescendo
  • Clarity Pharmaceuticals Ltd (CU6 AU): Steady Progress Toward Commercialization
  • Santos Ltd – Next Week At A Glance – 23-27 Jun 2025
  • Metcash Outlook: Tobacco Sales vs Rate Cuts
  • Platinum Asset Management – The Overnight Report: Waiting & Watching
  • The Overnight Report: FOMO Is Back (Nvidia Too)
  • Artrya Ltd – Australian Broker Call *Extra* Edition – Jun 18, 2025


Santos (STO AU): Why FIRB Should Block ADNOC’s Takeover

By David Blennerhassett

  • There is no shortage of opinions on whether FIRB will back/oppose the Santos Offer, as Australia seeks to balance attracting foreign investment with the need to protect national interests.
  • The key question is how Australia benefits from Santos becoming a foreign-owned national oil/gas company? Can ADNOC accelerated/bolster existing projects/operations? Can ADNOC better negotiate native title rights for domestic supply? 
  • And should Australia readily sell 100% in a critical infrastructure complex; yet if the roles were reversed, foreigners are capped at 49% ownership in UAE’s similar critical assets? 

New World Resources (NWC AU): Kinterra Firms A$0.057/Share Off-Market Offer

By David Blennerhassett

  • Kinterra has now firmed an off-market Offer for at A$0.057/share for copper-play New World Resources (NWC AU). There is no minimum acceptance condition.
  • Kinterra’s Bidder’s Statement will be dispatched no later than the 10th July, at which time the Offer will open.  A Target statement is expected 15 days later.
  • Central Asia Metals (CAML LN) has matchng rights. Expect those rights to be used.  

New World Resources (NWC AU): CAML Raises to A$0.062, Next Move Kinterra

By Arun George

  • After market close, CAML acquired a total of 253.0 million New World Resources (NWC AU) shares via off-market trades, representing 7.08% of the outstanding shares, at A$0.062 per share.
  • Central Asia Metals (CAML LN)’s scheme and takeover offer has increased to A$0.062, a 12.7% premium to CAML’s previous A$0.055 offer and an 8.8% premium to Kinterra’s A$0.057 offer.
  • CAML and Kinterra’s stake prevents the other from exercising compulsory acquisition rights. Despite CAML’s offer representing a 121.4% premium to the undisturbed price, there remains headroom for a bidding war. 


Clarity Pharmaceuticals Ltd (CU6 AU): Steady Progress Toward Commercialization

By Tina Banerjee

  • Clarity Pharmaceuticals Ltd (CU6 AU) initiated Phase 3 trial for its lead diagnostic candidate 64Cu-SARbisPSMA. The trial intends to gather data for filing of the product.
  • The company’s cash position at the end of the March quarter was A$95M, with additional A$11M received in April for FY24 R&D tax incentive. This provides cash runway through 2H26.
  • Clarity has built a robust supply of copper-64 with a wide network of product manufacturers in preparation for its two Phase 3 trials in prostate cancer and potential commercialization. 

Santos Ltd – Next Week At A Glance – 23-27 Jun 2025

By FNArena

  • A brief look at important company events and economic data releases next week

Metcash Outlook: Tobacco Sales vs Rate Cuts

By FNArena

  • Metcash’s FY25 result was solid, showing resilience in Food & Liquor.
  • Signs are positive for a recovery in Hardware, but rate cuts are key


The Overnight Report: FOMO Is Back (Nvidia Too)

By FNArena

  • A global perspective on what happened overnight


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Quantitative Analysis: ASX Short Interest Weekly (Jun 20th): Sigma Pharmaceuticals and more

By | Daily Briefs, Quantitative Analysis

In today’s briefing:

  • ASX Short Interest Weekly (Jun 20th): Sigma Pharmaceuticals, Brambles, Cochlear, Yancoal Australia


ASX Short Interest Weekly (Jun 20th): Sigma Pharmaceuticals, Brambles, Cochlear, Yancoal Australia

By Ke Yan, CFA, FRM

  • We analyzed the changes in short interest of ASX Stocks as of Jun 20th (reported today). The aggregated short interest was USD25.9bn.
  • We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases & decreases in short value, short as multiple of ADT.
  • We highlight short interest changes in Sigma Pharmaceuticals, Brambles, Cochlear, Yancoal Australia, Evolution Mining, BHP, National Australia Bank, Westpac.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: HD Hyundai Heavy Industries , LOTTE Corporation and more

By | Daily Briefs, South Korea

In today’s briefing:

  • EB Event Trade Setup: HD KSOE Lining up a New Deal with HD Hyundai Heavy as the Underlying
  • Lotte Corp Sells 145 Billion Won Worth of Treasury Shares to Lotte Moolsan  – Negative Governance


EB Event Trade Setup: HD KSOE Lining up a New Deal with HD Hyundai Heavy as the Underlying

By Sanghyun Park

  • HD KSOE plans a second EB similar to earlier this year: a zero-coupon, 2% HD Hyundai Heavy stake with 13–15% premium, aiming to raise around ₩850 billion.
  • With Korea’s Commercial Act revision expected by July 4, EB deals risk director liability; HD KSOE aims to raise cash now before stricter rules limit easy board-approved EB issuance.
  • Targeting a short in HD Hyundai Heavy triggered by HD KSOE’s board approval before July 4; consider hedging with a long position in HD KSOE due to ongoing sector catalysts.

Lotte Corp Sells 145 Billion Won Worth of Treasury Shares to Lotte Moolsan  – Negative Governance

By Douglas Kim

  • After the market close on 26 June, LOTTE Corporation (004990 KS) announced that it sold 5% of its outstanding shares worth 145 billion won to its affiliate Lotte Moolsan. 
  • This is poor corporate governance since the company should be cancelling the treasury shares instead.
  • Major reason why Lotte Corp sold its 5% stake in the company to Lotte Moolsan is to have the Lotte Group Chairman’s Shin family maintain control over the Lotte Group. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ESG: Lotte Corp Sells 145 Billion Won Worth of Treasury Shares to Lotte Moolsan  – Negative Governance and more

By | Daily Briefs, ESG

In today’s briefing:

  • Lotte Corp Sells 145 Billion Won Worth of Treasury Shares to Lotte Moolsan  – Negative Governance


Lotte Corp Sells 145 Billion Won Worth of Treasury Shares to Lotte Moolsan  – Negative Governance

By Douglas Kim

  • After the market close on 26 June, LOTTE Corporation (004990 KS) announced that it sold 5% of its outstanding shares worth 145 billion won to its affiliate Lotte Moolsan. 
  • This is poor corporate governance since the company should be cancelling the treasury shares instead.
  • Major reason why Lotte Corp sold its 5% stake in the company to Lotte Moolsan is to have the Lotte Group Chairman’s Shin family maintain control over the Lotte Group. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Max Healthcare Institute, Kalpataru Limited and more

By | Daily Briefs, India

In today’s briefing:

  • Quiddity Leaderboard NIFTY Sep25: Multiple Changes to Expected ADDs/DELs; New Pair Trade Ideas
  • Kalpataru Ltd IPO – Cemented by Debt Repayment


Quiddity Leaderboard NIFTY Sep25: Multiple Changes to Expected ADDs/DELs; New Pair Trade Ideas

By Janaghan Jeyakumar, CFA

  • NIFTY 50 represents the 50 largest stocks listed in the National Stock Exchange (NSE) of India and the NIFTY Next 50 index tracks the next 50 largest names.
  • In this insight, we take a look at the names leading the race to become ADDs/DELs for these indices during the September 2025 index rebal event.
  • We see two changes for NIFTY 50 and five changes for NIFTY 100 in the September 2025 rebal.

Kalpataru Ltd IPO – Cemented by Debt Repayment

By Akshat Shah

  • Kalpataru Limited (KTARU IN) is looking to raise about US$184m in its upcoming India IPO.
  • Kalpataru (KL) is an integrated real estate developer involved in identification and acquisition of land, planning, designing, execution, sales, and marketing of its projects.
  • In this note, we take a quick look at the company’s past performance and the IPO valuations.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: FWD Group Holdings, Anjoy Foods Group, Seazen Holdings , Viomi Technology Co Ltd and more

By | China, Daily Briefs

In today’s briefing:

  • FWD Group (1828 HK): Offering Details & Index Entry Timeline
  • FWD IPO – Valuation Down but Its Difficult to Get Excited About It
  • FWD Group (1828 HK) IPO: Valuation Insights
  • Anjoy Foods (2648 HK): Float Cap Restricts Global Index Inclusion
  • FWD IPO Valuation: Intangible Assets Is the Key (Vs. Peers)
  • Lucror Analytics – Morning Views Asia
  • VIOT: Viomi hits a few speed bumps in the road. Adjusting our valuation target to 4.00


FWD Group (1828 HK): Offering Details & Index Entry Timeline

By Brian Freitas

  • FWD Group Holdings (FWD HK) is looking to raise up to HK$3.99bn (US$508m) in its IPO, valuing the company at HK$48.82bn (US$6.22bn).
  • Cornerstone investors will take up more than half the base offering and that will delay index inclusion to well into 2026.
  • FWD Group Holdings (FWD HK) could be added to the HSCI Index and Southbound Stock Connect in December. That could bring some buying into the stock from mainland investors.

FWD IPO – Valuation Down but Its Difficult to Get Excited About It

By Sumeet Singh

  • FWD Group, a pan-Asian life insurer founded by Richard Li, aims to raise around US$442m in its HK IPO.
  • FWD is a pan-Asia life insurer operating in ten markets including Hong Kong (and Macau), Thailand (and Cambodia), Japan, the Philippines, Indonesia, Singapore, Vietnam and Malaysia.
  • We looked at the company’s past performance in our previous notes. In this note we talk about the IPO pricing.

FWD Group (1828 HK) IPO: Valuation Insights

By Arun George

  • FWD Group Holdings (1828 HK) has launched its IPO to raise US$442 million at HK$38.00 per share. The shares will be listed on 7 July.
  • I previously discussed the IPO in FWD Group IPO: The Investment Case
  • The IPO price implies a discount to peers’ multiples. A discount is warranted as FWD is smaller than its peers. FWD is fairly valued at the IPO price. 

Anjoy Foods (2648 HK): Float Cap Restricts Global Index Inclusion

By Dimitris Ioannidis

  • Anjoy Foods Group (2648 HK) debuts on the HKEX on 4 July, at a market cap of ~$2.8bn, raising ~$340m.
  • The security is expected to fail the minimum float cap threshold of Global-F and therefore be excluded even after the lock-up expiry.
  • Anjoy Foods Group (2648 HK) can be added to Global-M at the November 2025 review if its market cap is assigned to the SmallCap segment.

FWD IPO Valuation: Intangible Assets Is the Key (Vs. Peers)

By Alec Tseung

  • Based on HKD 38 offer price per share, FWD has a market capitalization of USD 6.1 billion, assuming the overallotment option is not exercised.
  • FWD’s P/FY’24 pro forma BV represents a significant discount to peers’ trading P/FY’24 BV since it has higher-than-peers intangible assets.
  • P/EV might be a fairer approach as it excludes intangible assets. On this basis, FWD valuation almost has no discount.

Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Seazen Group, Shui On Land, West China Cement
  • Front-end UST yields continued to decline yesterday, as the market priced in higher expectations for Fed easing, and on the back of a reasonable auction of 5Y notes.
  • The yield on the 2Y UST fell 4 bps to 3.78%, while that on the 10Y UST was unchanged at 4.29%. Equities hovered near a record high level, with the S&P 500 flat at 6,092, while the Nasdaq rose 0.3% to 19,974.

VIOT: Viomi hits a few speed bumps in the road. Adjusting our valuation target to 4.00

By Zacks Small Cap Research

  • Viomi recently launched a new filtration system that produces mineral water-like output, which could be a differentiated product in the market, enabling Viomi to gain a share in an increasingly crowded filtration market.
  • The company’s inability to file a timely 20-F with the SEC, combined with a recent change in auditors, will likely raise concerns among investors.
  • Viomi’s strong balance sheet could enable it to pursue multiple growth strategies (expansion, new products, M&A) over the next 3-5 years.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Equity Bottom-Up: Japan Activist Watch | Square Enix and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • Japan Activist Watch | Square Enix, DaitoTrust, Iriso & INES
  • Seibu Holdings (TSE: 9024) – Asset-Rich Platform With Significant Upside from Monetization
  • How Apple Accidentally Built China’s Tech Superpower and Can’t Escape with Patrick McGee
  • Micron Q325 Earnings: NAND’s Surprising Rebound While HBM Already @$6 Billion Annual Run Rate.
  • Commonwealth Bank of Australia – The Overnight Report: Geopolitical Crescendo
  • The end of the UK’s ‘bailout era’
  • Clarity Pharmaceuticals Ltd (CU6 AU): Steady Progress Toward Commercialization
  • Memory Monitor: Micron Reinforces AI Memory Tailwinds, But Broader Supply Chain Recovery Gradual
  • Novartis CEO: Medical Innovation, Tech Partnerships, and European Competitiveness
  • AAON Secures $200M in Liquid Cooling Orders—Is This the Future of AI Data Centers?


Japan Activist Watch | Square Enix, DaitoTrust, Iriso & INES

By Mark Chadwick

  • Activist investors 3D Investment Partners and Dalton Investments have both taken meaningful stakes in Square Enix – highlights capital inefficiency and poor margin profile
  • Daito Trust sits on over ¥100bn in net cash, an arguably excessive cushion for a mature operator with steady cash flows. Silchester have taken note
  • Iriso Electronic and INES both trade below book value. Attractive value plays for small cap funds.

Seibu Holdings (TSE: 9024) – Asset-Rich Platform With Significant Upside from Monetization

By Rahul Jain

  • Seibu’s FY25 results were buoyed by a ¥350 bn real estate securitization, driving operating profit to ¥263 bn and showcasing the deep value embedded in its property portfolio.
  • Management plans to monetize ~¥1.35 trillion of urban assets over the next 3–5 years, shift to a capital-light hotel model, and revitalize transport margins via fare revisions.
  • Even at the current price of ¥4,868, Seibu trades at a ~45% discount to its fully adjusted SoTP value (~¥8,873/share)—implying substantial re-rating potential if monetization proceeds as planned.

How Apple Accidentally Built China’s Tech Superpower and Can’t Escape with Patrick McGee

By Analyse Asia with Bernard Leong

  • ndia does not have a top-down method for executing a five year plan like China does
  • hina’s supply chain is vast and highly competitive, with India unlikely to replicate its success
  • hina wants technology transfer to be one-way gate, inhibiting India’s ability to compete
  • atrick Magee studied religion before becoming a financial journalist and eventually writing about Apple’s dependence on China

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Micron Q325 Earnings: NAND’s Surprising Rebound While HBM Already @$6 Billion Annual Run Rate.

By William Keating

  • Q325 revenues of $9.3 billion, up 15% QoQ and up 37% YoY and $500 million above the guided midpoint. This represented a new quarterly revenue record for the company
  • Micron forecasted current quarter revenues of $10.7 billion, up 15% QoQ, with gross margin of 42%, up 300 basis points sequentially
  • HBM negotiations for 2026 supply & pricing still ongoing. Could Micron be holding out for a better deal?


The end of the UK’s ‘bailout era’

By Behind the Money

  • UK government owned Royal Bank of Scotland (RBS) for 17 years, impacting taxpayer finances
  • RBS’s aggressive expansion and risky acquisitions led to vulnerabilities and exposure to toxic assets
  • Government bailed out RBS with £45.5 billion, taking an 84% stake in the bank and preventing a collapse in 2008.

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Clarity Pharmaceuticals Ltd (CU6 AU): Steady Progress Toward Commercialization

By Tina Banerjee

  • Clarity Pharmaceuticals Ltd (CU6 AU) initiated Phase 3 trial for its lead diagnostic candidate 64Cu-SARbisPSMA. The trial intends to gather data for filing of the product.
  • The company’s cash position at the end of the March quarter was A$95M, with additional A$11M received in April for FY24 R&D tax incentive. This provides cash runway through 2H26.
  • Clarity has built a robust supply of copper-64 with a wide network of product manufacturers in preparation for its two Phase 3 trials in prostate cancer and potential commercialization. 

Memory Monitor: Micron Reinforces AI Memory Tailwinds, But Broader Supply Chain Recovery Gradual

By Vincent Fernando, CFA

  • Micron Results Beat Across the Board, AI Product Mix Drives Gross Margin Upside
  • No Evidence Yet of Hyperscaler Pullback, But No Significant Increase in Outlook Either
  • Conclusion: AI-Driven Strength Continues, But Divergence Across the Memory Supply Chain Persists

Novartis CEO: Medical Innovation, Tech Partnerships, and European Competitiveness

By In Good Company with Nicolai Tangen

  • The CEO of Novartis, with a medical background, emphasizes the importance of focusing on breakthrough innovations and patient impact in leading the company
  • Implemented changes to focus on innovative medicines by spinning off non-core businesses, leading to unlocking significant value for the company
  • Novartis structures R&D differently by having a strategy and growth function, focusing on key therapeutic areas, and investing in advanced technology platforms like radio ligand therapies and cell and gene therapies

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


AAON Secures $200M in Liquid Cooling Orders—Is This the Future of AI Data Centers?

By Baptista Research

  • AAON Inc.’s first quarter of 2025 results highlight a mix of positive growth and operational challenges, painting a complex picture for potential investors.
  • The company’s core strategic pillars focus on innovation, sustainable growth, and operational excellence, positioning it for long-term advancement.
  • This focus is evident in its commitment to developing new products, like heat pumps and data center cooling solutions, which align with its innovative goals.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): HK/China Real Estate Bottoming Out and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • HK/China Real Estate Bottoming Out, Upcoming Re-Rating with Multiple Catalysts
  • Ohayo Japan | Continued Rally
  • Know This Before Investing in African Miners
  • EP 123: Marvell ASIC TAM, ASIC Challenges Remain, More Semi 2.0


HK/China Real Estate Bottoming Out, Upcoming Re-Rating with Multiple Catalysts

By Jacob Cheng

  • 2025 YTD, HK/China RE companies rebounded from recent lows (10% – 30%), and we think this will continue and turn into a sector re-rating
  • A combination of reduced global geopolitical tensions, expected monetary easing from US, China’s fiscal and monetary stimulus, HK’s robust capital inflow and lower interbank rate will support re-rating
  • Despite recent rebound, valuation remains attractive.  We recommend LONG COLI 688 HK and SHKP 16 HK.  For higher risk tolerance and higher beta, we recommend NWD 17 HK

Ohayo Japan | Continued Rally

By Mark Chadwick

  • US stocks surged Thursday, with the S&P 500 rising 0.8% to 6,141, just below its record high
  • Nike reported a 12% drop in fourth-quarter revenue to ¥1.78 trillion; gross margins down 4.4 percentage points due to excess inventory and tariffs
  • Kyocera approved the reappointment of Chairman Goro Yamaguchi despite opposition from Oasis Management, citing poor performance

Know This Before Investing in African Miners

By Money of Mine

  • Multiple companies involved in competitive bidding war in Arizona for mining project
  • Kinterra makes bid for New World Resources at 5.7 cents per share
  • Deal with RCF allows Kinterra to increase stake in company to over 19%

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


EP 123: Marvell ASIC TAM, ASIC Challenges Remain, More Semi 2.0

By The Circuit

  • Marvell’s technical presentations were longer than expected but well-received, showcasing their differentiation from Broadcom
  • Marvell has a deep pool of technical talent and a framework for explaining their innovations effectively
  • Challenges with the custom business model being lumpy and heavily cyclical, with uncertainties in revenue pipelines and scaling projects with hyperscalers

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Apple , Micron Technology, Aaon Inc, Academy Sports & Outdoors , Anthropic, Appian Corp, Mastec Inc, Grace Therapeutics, Avis Budget Group and more

By | Daily Briefs, United States

In today’s briefing:

  • How Apple Accidentally Built China’s Tech Superpower and Can’t Escape with Patrick McGee
  • Micron Q325 Earnings: NAND’s Surprising Rebound While HBM Already @$6 Billion Annual Run Rate.
  • AAON Secures $200M in Liquid Cooling Orders—Is This the Future of AI Data Centers?
  • Micron 3Q25 Beats by 13%, 4Q Guidance Beats by 14%. Consensus Forecasts for FY27 Too Low by 25-30%
  • Academy Sports + Outdoors Expands Aggressively—Are These New Stores a Retail Masterstroke?
  • Anthropic’s to Every One of Us
  • Appian Corporation: Process Infrastructure & Data Fabric Integration For A Significant Competitive Advantage In The Marketplace!
  • MasTec Inc. Cashes In on Renewable Energy Wave with Strategic Alliances & Record Backlog!
  • GRCE: NDA Submitted
  • How Avis Budget Group Turns Rising Vehicle Prices into Opportunity with Flexible Cost Strategies!


How Apple Accidentally Built China’s Tech Superpower and Can’t Escape with Patrick McGee

By Analyse Asia with Bernard Leong

  • ndia does not have a top-down method for executing a five year plan like China does
  • hina’s supply chain is vast and highly competitive, with India unlikely to replicate its success
  • hina wants technology transfer to be one-way gate, inhibiting India’s ability to compete
  • atrick Magee studied religion before becoming a financial journalist and eventually writing about Apple’s dependence on China

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Micron Q325 Earnings: NAND’s Surprising Rebound While HBM Already @$6 Billion Annual Run Rate.

By William Keating

  • Q325 revenues of $9.3 billion, up 15% QoQ and up 37% YoY and $500 million above the guided midpoint. This represented a new quarterly revenue record for the company
  • Micron forecasted current quarter revenues of $10.7 billion, up 15% QoQ, with gross margin of 42%, up 300 basis points sequentially
  • HBM negotiations for 2026 supply & pricing still ongoing. Could Micron be holding out for a better deal?

AAON Secures $200M in Liquid Cooling Orders—Is This the Future of AI Data Centers?

By Baptista Research

  • AAON Inc.’s first quarter of 2025 results highlight a mix of positive growth and operational challenges, painting a complex picture for potential investors.
  • The company’s core strategic pillars focus on innovation, sustainable growth, and operational excellence, positioning it for long-term advancement.
  • This focus is evident in its commitment to developing new products, like heat pumps and data center cooling solutions, which align with its innovative goals.

Micron 3Q25 Beats by 13%, 4Q Guidance Beats by 14%. Consensus Forecasts for FY27 Too Low by 25-30%

By Nicolas Baratte

  • Results and Guidance beat, driven by HBM very fast growth. HBM also generates higher margins and sucks up DRAM capacity, a secondary benefit. 
  • HBM is still in year-2 of a 5-year journey. Industry revenues double in 2025 and Micron HBM revenue increase 5x in FY25. Expect Micron HBM to double in FY26. 
  • Consensus is a tad too low for FY26, likely 10% too low. Consensus is very low for FY27, likely 25-30% too low. It’s hard for the sell-side to forecast hyper-growth.

Academy Sports + Outdoors Expands Aggressively—Are These New Stores a Retail Masterstroke?

By Baptista Research

  • Academy Sports and Outdoors navigated through a challenging environment in the first quarter of fiscal 2025 marked by new complexities due to newly imposed tariffs and macroeconomic uncertainties.
  • Their financial performance for the quarter reported sales of $1.35 billion, slightly down by 0.9% from the previous year, translating to a negative 3.7% in comparable sales.
  • Despite unfavorable weather conditions early in the quarter impacting sales, momentum improved towards the end as milder temperatures arrived in March and April, yielding a positive comp in April thanks to strategic initiatives and partnerships.

Anthropic’s to Every One of Us

By Fallacy Alarm

  • Anthropic is a reckless and entitled AI start-up, symbolic of a tech industry that is completely out of control and drunk on its own success.

  • A judge in California just ruled that they can use copyrighted data without permission to train their models.

  • This allows them to make money of other people’s works without compensating them adequately.


Appian Corporation: Process Infrastructure & Data Fabric Integration For A Significant Competitive Advantage In The Marketplace!

By Baptista Research

  • Appian Corporation reported its financial results for the first quarter of 2025, presenting an optimistic yet complex picture of its ongoing performance.
  • The company’s cloud subscription revenue demonstrated a significant increase of 15% year-over-year, amounting to $99.8 million.
  • Total subscription revenue rose by 14% to $134.4 million, contributing to an overall revenue growth of 11% year-over-year to $166.4 million.

MasTec Inc. Cashes In on Renewable Energy Wave with Strategic Alliances & Record Backlog!

By Baptista Research

  • MasTec, a diversified infrastructure construction company, reported robust financial performance in the first quarter of 2025, exceeding guidance in key metrics such as revenue, EBITDA, and EPS.
  • The company’s revenue stood at $2.85 billion, with adjusted EBITDA of $164 million, marking significant overperformance.
  • The strong results came amid macroeconomic volatility, highlighting MasTec’s structural demand strength across its diversified business segments.

GRCE: NDA Submitted

By Zacks Small Cap Research

  • Grace is a clinical-stage, biotechnology company focused on rare disease.
  • Its lead program, GTx-104, is a novel injectable formulation of nimodipine for the treatment of aneurysmal subarachnoid hemorrhage (aSAH).
  • Other programs include GTX-102 for Ataxia Telangiectasia & GTX-101 for postherpetic neuralgia.

How Avis Budget Group Turns Rising Vehicle Prices into Opportunity with Flexible Cost Strategies!

By Baptista Research

  • Avis Budget Group presented a mixed set of results for the first quarter of 2025, revealing substantial challenges alongside strategic advancements.
  • The company reported a decline in total revenue to $2.4 billion, compared with $2.5 billion in the same period of the previous year.
  • This decline was attributed to calendar shifts and a 2% decrease in pricing, set against softer commercial demand and relatively strong leisure demand.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars